Analysis of type III secreted proteins of C. trachomatis
沙眼衣原体III型分泌蛋白分析
基本信息
- 批准号:6930624
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Oculogenital disease induced by the sexually transmitted pathogen Chlamydia trachomatis manifests as a range of acute and chronic sequelae that represent a significant source of morbidity in humans. Chlamydiae are obligate intracellular pathogens that develop within a membrane-bound vacuole termed an inclusion. Although inclusions represent a privileged niche, sequestered chlamydiae possess the ability to modulate host-cell functions in order to create and maintain a permissive growth environment. Chlamydiae express a type III secretion system that, in other gram-negative pathogens, is a secretion mechanism strongly associated with pathogenesis. I have identified two chlamydial type III substrates and propose to identify specific interactions of these substrates with host molecules and delineate the consequences of those interactions. Using yeast two-hybrid assays, I propose to identify specific interactions between chlamydial effectors and host proteins. These elucidated in vitro interactions will be confirmed in chlamydial infections using a series of crosslinking and coprecipitation assays in combination with mass spectroscopy. The consequences of these interactions will be investigated in vitro by ectopic expression of effector proteins followed by biochemical confirmation of detected effects in infected cells. The chlamydial type III secretion system represents an attractive, yet unexplored, mechanism to achieve modulation of host cell activities. By specifically elucidating which host pathways are targeted I will gain insight into i) molecular mechanisms employed by Chlamydia to sculpt their intracellular environment and ii) what host cellular processes are important to chlamydial survival.
描述(由申请人提供):性传播的病原体沙丘瘤引起的眼源性疾病表现为一系列急性和慢性后遗症,代表了人类发病的重要来源。衣原体是在膜结合的液泡中发育的务实的细胞内病原体,称为包容性。尽管夹杂物代表了特权的利基市场,但隔离的衣原体具有调节宿主 - 细胞功能以创建和维持宽松的增长环境的能力。衣原体表达了III型分泌系统,在其他革兰氏阴性病原体中,它是与发病机理密切相关的分泌机制。我已经确定了两种衣原体III型底物,并提出要确定这些底物与宿主分子的特定相互作用,并描述这些相互作用的后果。我建议使用酵母两种杂交测定法,以确定衣原体效应子和宿主蛋白之间的特定相互作用。这些阐明的体外相互作用将在衣原体感染中使用一系列交联和共沉淀测定法与质谱相结合。这些相互作用的后果将在体外通过异位表达效应蛋白的异位表达,然后对感染细胞中检测到的作用进行生化确认。衣原体III型分泌系统代表了一种有吸引力但未开发的机制,可以调节宿主细胞活性。通过明确阐明哪种宿主途径的目标,我将深入了解i)衣原体用来雕刻其细胞内环境的分子机制; ii)ii)哪些宿主细胞过程对衣原体生存至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
KENNETH A FIELDS的其他基金
Chlamydia type III effectors affecting the host actin-based cytoskeleton
III 型衣原体效应子影响宿主肌动蛋白细胞骨架
- 批准号:1063293510632935
- 财政年份:2023
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae
解决肺炎衣原体的遗传易处理性和物种特异性感染生物学
- 批准号:1057136610571366
- 财政年份:2022
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Engineered promoters for finely tuned gene expression in Chlamydia
用于微调衣原体基因表达的工程启动子
- 批准号:1009295310092953
- 财政年份:2020
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Mutagenesis in Chlamydia trachomatis via allelic exchange
沙眼衣原体通过等位基因交换进行诱变
- 批准号:92156379215637
- 财政年份:2016
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Mutagenesis in Chlamydia trachomatis via allelic exchange
沙眼衣原体通过等位基因交换进行诱变
- 批准号:91255969125596
- 财政年份:2016
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
The role of Perforin-2 in Chlamydia pathogenesis
Perforin-2 在衣原体发病机制中的作用
- 批准号:91283319128331
- 财政年份:2015
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
The role of disulfide bonding in type III secretion of Chlamydia spp.
二硫键在衣原体 III 型分泌中的作用。
- 批准号:81909268190926
- 财政年份:2011
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
The role of disulfide bonding in type III secretion of Chlamydia spp.
二硫键在衣原体 III 型分泌中的作用。
- 批准号:82683498268349
- 财政年份:2011
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Chlamydia pneumoniae-Specific Inclusion Membrane Proteins
肺炎衣原体特异性包涵膜蛋白
- 批准号:73060097306009
- 财政年份:2007
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Chlamydia pneumoniae-Specific Inclusion Membrane Proteins
肺炎衣原体特异性包涵膜蛋白
- 批准号:74680027468002
- 财政年份:2007
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
相似国自然基金
小地老虎触角miRNAs的鉴定及其对信息素结合蛋白PBP2的调控分析
- 批准号:31772164
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
microRNA-138与BAG3协同抑制人子宫颈癌HeLa细胞迁移的分子机制研究
- 批准号:31601036
- 批准年份:2016
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
HeLa细胞上皮-间质相变中的关键基因相互作用网络机制研究
- 批准号:11474117
- 批准年份:2014
- 资助金额:90.0 万元
- 项目类别:面上项目
融合魏斯氏菌转化槲皮素的产物中抑制HeLa细胞的组分结构及机制
- 批准号:31471589
- 批准年份:2014
- 资助金额:90.0 万元
- 项目类别:面上项目
HeLa细胞中人乳头瘤病毒E6/E7基因转录的表观遗传学调控机制
- 批准号:31301073
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Human RNAPII Structure/Function in Pausing & Elongation
暂停中的人类 RNAPII 结构/功能
- 批准号:70947227094722
- 财政年份:2006
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Identification of Brucella Type IV Effectors
布鲁氏菌 IV 型效应子的鉴定
- 批准号:71402587140258
- 财政年份:2005
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Molecular Targeting of MLL and Associated Factors
MLL 的分子靶向及相关因素
- 批准号:69631686963168
- 财政年份:2005
- 资助金额:$ 10.8万$ 10.8万
- 项目类别:
Bacteriophage gene transfer for HIV vaccine delivery
用于 HIV 疫苗递送的噬菌体基因转移
- 批准号:68927476892747
- 财政年份:2005
- 资助金额:$ 10.8万$ 10.8万
- 项目类别: